GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Eli Lilly Unusual Options Activity
"Trump Organization" stock price rose in pre-market trading, with mixed movements in the three major US stock index futures. | Tonight's focus
①Trump Media Technology Group rose nearly 9% in pre-market trading; ②Alibaba fell more than 4%, JD.com fell more than 6%; ③Wolfspeed is set to receive a $0.75 billion grant from the US Department of Commerce; ④Eli Lilly and Co is establishing the China Medical Innovation Center and Innovation Incubator in Beijing.
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Hims +6% Monday After FDA Said it Might Halt Hims Weight Loss Drug Sales Friday
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Lilly Reports Positive Data for Omvoh Versus Stelara in Crohn's